Advertisement

Thromboxane production in the blood of women increases after menopause whereas tumor necrosis factor is reduced in women compared with men

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Previously we have shown that incubation of heparinized blood with a low dose of lipopolysaccharides (5 ng/ml) resulted in a 60% higher generation of TxB2 in the blood of young men as compared with that of young women. In the present study, we investigated a group consisting of 38 healthy men and 38 healthy postmenopausal women aged 50–73 years with no drug use and no known chronic disease. In contrast to our earlier observation that young men produce more TxB2 than young women, no significant difference was observed between the men and women when all the participants above 50 years of age were included (5.7 ± 0.6 ng/1 for men versus 5.2 ± 0.7 ng/1 for women). However, a strong correlation was found with simple regression analysis when increasing TxB2 generation was compared with years after menopause (P < 0.0001). No such correlation was observed for increasing age of men and their TxB2 production. The LPS stimulation system of whole blood was also used to evaluate the production of tumor necrosis factor (TNF-α) in older people. Men were found to generate 60% more TNF-α than women, but no correlation was found between increasing age of women and TNF-a production as observed with TxB2. Risk factors such as SDS-cholesterol, fibrinogen and factor VII were the same in men and women, whereas total cholesterol was higher in women than in men (P < 0.05). Since TxA2 is known to be a mediator of atherosclerosic-induced lesions and TNF-α is a well-established indicator of inflammatory reactions, we propose that the reduced production of TxB2 and TNF-α in women in our model system may partially explain the lower incidence of atherosclerosis in women as compared with men, and the phenomenon of increased incidence of this disease after menopause.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. World Health Statistics 1977 I. WHO, Geneva1977
        • Kannel W.B.
        • Hjortland N.C.
        • NcNamara P.M.
        • Gordon T.
        Menopause and risk of cardiovascular disease.
        Ann. Intern. Med. 1976; 85: 447
        • Gordon T.
        • Kannel W.B.
        • Hjortland N.C.
        • McNamara P.M.
        Menopause and coronary heart disease. The Framingham study.
        Ann. Int. Med. 1978; 89: 157
        • Stampfer N.J.
        • Wilett W.C.
        • Coldits G.A.
        • Rosner B.
        • Speizer F.E.
        • Hennekens C.H.
        A prospective study of postmenopausal estrogen therapy and coronary heart disease.
        N. Engl. J. Med. 1985; 313: 1044
        • Henderson B.E.
        • Paganini-Hill A.
        • Ross R.K.
        Estrogen replacement therapy and protection from acute myocardial infarction.
        Am. J. Obstet. Gynecol. 1988; 159: 312
        • Gordon T.
        • Castelli W.P.
        • Hjortland N.C.
        • Kannel W.B.
        • Dauber T.R.
        High density lipoprotein as a protective factor against coronary heart disease. The Framingham study.
        Am. J. Med. 1977; 62: 707
        • Castelli W.P.
        • Garrison R.J.
        • Wilson P.W.
        • Abbott R.D.
        • Kalousdian S.
        • Kannel W.B.
        Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study.
        J. Am. Med. Assoc. 1986; 256: 2835
        • Kannel W.B.
        Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study.
        Am. J. Epidemiol. 1979; 109: 405
      2. 2nd Edn. Smoking and Health: A report of Surgeon General. U.S. Dept of Health, Education and Welfare, Washington DC1979 (Publ. 79-50066)
        • Bailey J.N.
        • Butler J.
        Anti-inflammatory drugs in experimental atherosclerosis, Part 6. Combination therapy with steroid and non-steroid agents.
        Atherosclerosis. 1985; 54: 205
        • Barath P.
        • Fishbein N.C.
        • Cao J.
        • Berenson J.
        • Helfant R.H.
        • Forrester J.S.
        Detection and localization of tumor necrosis factor in human atheroma.
        Am. J. Cardiol. 1990; 65: 297
        • Shrinska V.A.
        • Konieczowski N.
        • Gerrity R.G.
        • Galang C.F.
        • Rebec N.V.
        Suppression of foam cell lesions in hypercholesterolemic rabbits by inhibition of thromboxane A2 synthesis.
        Arteriosclerosis. 1988; 8: 359
        • Hansen J.-B.
        • Wilsgård U.
        • Olsen J.O.
        • Svensson B.
        • Østerud B.
        The effect of lipopolysaccharides (LPS) on generation of thromboxane A2 and thromboplastin activ ity in whole blood of males, females and females on oral contraceptives.
        Thromb. Haemost. 1989; 61: 491
        • Burnstein N.
        • Scholevik H.R.
        • Morgan R.
        Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions.
        J. Lip. Res. 1970; 11: 583
        • Østerud B.
        • Rapaport S.I.
        Synthesis of intrinsic factor X activator. Inhibition of formed activator by antibodies to factor VIII and to factor IX.
        Biochemistry. 1970; 9: 1854
        • Inada Y.
        • Okamoto H.
        • Kanai S.
        • Tamaura Y.
        Faster determination of clottable fibrinogen in human plasma: an improved method and kinetic study.
        Clin. Chem. 1978; 24: 351
        • Østerud B.
        Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes.
        J. Leuk. Biol. 1992; 51: 462
        • Salmon J.A.
        A radioimmunoassay for 6-ketoprostaglandin Fl.
        Prostaglandins. 1979; 15: 383
        • Van Lenten B.J.
        • Fogelman A.M.
        • Haberland N.E.
        • Edwards P.A.
        The role of lipoproteins and receptor mediated endocytosis in the transport of bacterial lipopolysaccharide.
        in: 2nd Edn. Proc. Natl. Acad. Sci. USA. 83. 1986: 2704
        • Østerud B.
        • Olsen J.O.
        • Wilsgård U.
        Effect of strenuous exercise on blood monocytes and their relation to coagulation.
        Med. Sci. Sports Exerc. 1989; 21: 374
        • Schwartz B.S.
        • Monroe N.C.
        Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro.
        J. Clin. Invest. 1986; 78: 1136
        • Beutler B.
        • Cerami A.
        Tumor necrosis factor, cachexia, shock, and inflammation: A common mediator.
        Annu. Rev. Biochem. 1988; 57: 505
        • Old L.J.
        Tumor necrosis factor.
        Scientific Am. 1988; 258: 41
        • Bourgain R.H.
        • Maes U.
        • Bracquet P.
        • Andries R.
        • Touquir L.
        • Braquet M.
        The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on the arterial wall.
        Prostaglandins. 1986; 30: 185
        • Barath P.
        • Fishbein N.C.
        • Cao J.
        • Berenson J.
        • Helfant R.H.
        • Forrester J.F.
        Detection of and localization of tumor necrosis factor in human atherome.
        Am. J. Cardiol. 1990; 65: 297
        • Barath P.
        • Fishbein N.C.
        • Cao J.
        • Berenson J.
        • Helfant R.H.
        • Forrester J.F.
        Tumor necrosis factor gene expression in human vascular smooth muscle cells detected by in situ hybridization.
        Am. J. Pathol. 1990; 137: 503
        • Osborne J.A.
        • Lefer M.A.
        Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbit.
        Am. Physiol. Soc. 1988; : H 318
        • Bang H.O.
        • Dyerberg J.
        • Nielsen A.B.
        Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos.
        Lancet. 1971; 1: 1143
        • Kromann N.
        • Green A.
        Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950–1974.
        Acta Med. Stand. 1980; 208: 401
        • Robertsen T.U.
        • Kato H.
        • Gordon T.
        • et al.
        Epidemiological studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: coronary heart risk factors in Japan and Hawaii.
        Am. J. Cardiol. 1977; 39: 244
        • Kromhout D.
        • Bosschieter E.B.
        • de Lazenne Coulander C.
        The inverse relation between fish consumption and 20-year mortality from coronary heart disease.
        N. Engl. J. Med. 1985; 312: 1205
        • Lee T.H.
        • Hoover R.L.
        • Williams J.D.
        • et al.
        Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function.
        N. Engl. J. Med. 1985; 312: 1217
        • Hansen J.-B.
        • Olsen J.O.
        • Wilsgård L.
        • Østerud B.
        Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis.
        J. Int. Med. 1989; 225: 133
        • Endres S.
        • Ghorbani R.
        • Kelley V.E.
        • et al.
        The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-I and tumor necrosis factor by mononuclear cells.
        N. Engl. J. Med. 1989; 320: 265
        • Punnonen R.
        • Seppala E.
        • Punnonen K.
        Effect of ovariectomy in humans on serum 6-keto-PgFI and TxB2 concentration and platelets fatty acid.
        Prost. Leuco. Med. 1987; 26: 85
        • Pilo R.
        • Aharony D.
        • Raz A.
        Testosterone potentiation of ionophore and ADP induced platelets aggregation: relationship to arachidonic acid metabolism.
        Thromb. Haemostas. 1981; 46: 538